Compare ROIV & RGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | RGLD |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 22.2B |
| IPO Year | 2021 | 1995 |
| Metric | ROIV | RGLD |
|---|---|---|
| Price | $28.05 | $259.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $27.56 | ★ $231.14 |
| AVG Volume (30 Days) | ★ 4.8M | 742.0K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | N/A | ★ 32.74 |
| EPS | N/A | ★ 6.69 |
| Revenue | $29,053,000.00 | ★ $1,030,471,000.00 |
| Revenue This Year | N/A | $94.64 |
| Revenue Next Year | $385.85 | $3.22 |
| P/E Ratio | ★ N/A | $40.30 |
| Revenue Growth | N/A | ★ 43.24 |
| 52 Week Low | $8.73 | $150.75 |
| 52 Week High | $30.33 | $306.25 |
| Indicator | ROIV | RGLD |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 38.68 |
| Support Level | $26.94 | $253.20 |
| Resistance Level | N/A | $305.47 |
| Average True Range (ATR) | 1.01 | 10.78 |
| MACD | -0.21 | -3.77 |
| Stochastic Oscillator | 32.70 | 0.95 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Royal Gold Inc enquires and manages precious metal royalties and streams with a focus on gold. The company purchases a percentage of the metal produced from a mineral property for an initial payment without assuming responsibility for mining operations. Similarly, precious metal streams are purchase agreements with mine operators providing the right to purchase all or a portion of one or more metals produced from a mine in exchange for an upfront deposit payment. Generally, Royal Gold does not work on the properties in which it holds royalty and streaming assets. The company owns a portfolio of producing, development, evaluation, and exploration royalties and streams, and the majority of group revenue is generated from Canada, Mexico, Chile, and the United States.